📢 LAST CALL!!!! Applications Closing Soon! The #EFSD and #Lilly European #Diabetes Research Programme is still accepting applications.
📅Deadline: 1 September 2026 | 🕛12:00 hrs CEST
🔗 👉 Apply now: europeandiabetesfoundation.o…
Programme supported by @LillyDiabetesIn.
#Funding

ALT EFSD call for applications for the EFSD and Lilly European Diabetes Research Programme, supporting European diabetes research and raising awareness of the burden of diabetes. Laboratory image is shown and the EFSD logo is shown on the bottom left corner. The europeandiabetesfoundation.org website is shown on the bottom right corner.
Ewan Pearson retweeted
This is shocking 😮. Just happened at the start of #ADA2026 Scientific Sessions.
Ewan Pearson retweeted
Genome-wide association study in @UK_biobank identifies an interaction between metformin and CUBN gene variant that predisposes to metformin-induced vitamin B12 deficiency in T2D patients. @daniel_f_carr @LivUNIISMIB @dundeeuni @harvardmed link.springer.com/article/10… 🔓
Ewan Pearson retweeted
To prescribe or not to prescribe? #SGLT2 inhibitors slow #CKD progression but it's unclear who with #T2D and mild/no CKD truly benefits. This new model predicts individual benefit, supporting more targeted prescribing. #PrecisionMedicine link.springer.com/article/10… 🔓@Exeter_Diabetes
Ewan Pearson retweeted
📢 Job Opportunity: @EASDnews is seeking an Editor-in-Chief for its flagship journal, @DiabetologiaJnl.
Lead one of the world’s top #diabetes #research journals.
🔗 Apply now: tinyurl.com/diab-eic-job-ad
🗓️ Closing date: 17 Nov 2025
#Diabetologia #Vacancy #EditorInChief
📢 Applications are open for the next EIC of Diabetologia! More info here tinyurl.com/diab-eic-job-ad
Ewan Pearson retweeted
Metabologia is a new journal from the EASD launched last month, sister journal of @DiabetologiaJnl and open for submissions! Go to metabologia.org/ for more info
Ewan Pearson retweeted
💥Those of us working in science comms are perhaps too fond of the word "gamechanging" but this research by @john_den_ @athattersley @Exeter_Diabetes, published today in @TheLancet and announced at #DUKPC25, truly deserves that description 💥
#Type2Diabetes #BetterCare
Ewan Pearson retweeted
5-drug precision prescribing for people with type 2 diabetes is here - @TheLancet our @ExeterMedmodel for optimising glucose lowering therapy using low-cost routine clinical features
Paper: thelancet.com/journals/lance…
Web calc: diabetesgenes.org/t2-treatme…
Ewan Pearson retweeted
Nearly 30years after her original diabetes diagnosis Mary had a genetic test identifying she had HNF1A MODY and could stop insulin injections hear from her and @ezpearson in our latest podcast 1in6b.com/series-3-episode-1… @Exeter_Diabetes @UofE_Research @RoyalDevonNHS @athattersley
Ewan Pearson retweeted
🎉Many thanks to Neave for sharing her inspiring PhD journey with us! 🚀📚 To all applicants, remember that recruitment closes on August 28th. Check out all projects and eligibility details on our website. gla.ac.uk/postgraduate/docto…⭐️💻📢
🌟 Meet Neave, a dedicated GP and one of our fantastic Cohort 2 Doctoral Fellows!
Interested in joining us? Have questions? Join our applicant webinar on August 9th at 11:30am!
📺 Watch video - buff.ly/3AewHVj
📅✨ Register for webinar - buff.ly/3YzYNo1
Ewan Pearson retweeted
New @imisophia study modelling impact of individual weight change trajectories prior to type 2 #diabetes diagnosis on subsequent longitudinal weight change in a Scottish population @dundeeuni @UoDMedicine @ezpearson #SCIDiabetes #T2D tinyurl.com/ydeh5ch7 🔓
Ewan Pearson retweeted
New podcast episode out: listen to @timfrayling and @rmfreathy describe finding FTO (the ‘fat gene’ as the media described it). Subscribe to ensure you don’t miss an episode ! @RoyalDevonNHS @ExeterMed @athattersley
1in6b.com/series-2-episode-1…
Ewan Pearson retweeted
Thank you to the entire SOPHIA Working Group 2, leading this important investigation of #obesity trajectories! Special shoutout to @ezpearson from @dundeeuni for sharing your insights in this blogpost 👏
Ewan Pearson retweeted
We're running a survey to gather insights on the challenges and barriers to progression in UK clinical academia.
If you're a medically qualified professional with experience in clinical academia, we'd like to hear from you.
Complete the survey➡️orlo.uk/mSpgq
Ewan Pearson retweeted
Low dose sulphonylurea plus DPP4 inhibitor lower blood glucose and enhance beta cell function without hypoglycaemia academic.oup.com/jcem/articl…
@ezpearson @UoDMedicine @dundeeuni @EndoSocJournals
Ewan Pearson retweeted
New—Analysis of type 2 #diabetes #heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort thelancet.com/journals/landi… #T2D
Ewan Pearson retweeted
💙 Thank you, from the bottom of our hearts, to everyone who this year joined the campaign to fight for fair and equal access to diabetes tech in Scotland. It's been an incredible journey so far.
Ewan Pearson retweeted
Ewan Pearson will take to the stage shortly for his Society for Endocrinology Medal Lecture! We spoke with him ahead of #SfEBES2023 to discuss his career, to find out about his upcoming lecture, and to hear his advice to future endos! Read more: ow.ly/i53250Q7S39 @ezpearson
Ewan Pearson retweeted
So excited to be launching our 1st podcast on #WorldDiabetesDay ! Thanks to Emma for sharing this emotional story of her amazing son Jack. Thanks also to @stevexoh for his expert help behind the scenes @athattersley @HQuinn01 @CNOEngland @carolynamills @parthaskar @ExeterMed
Our experts have launched a brilliant podcast this #WorldDiabetesDay. Mum Emma talks about Jack-diagnosed with neonatal #diabetes at 2wks. His life was transformed by switching treatment after our team found a genetic cause
🎧apple.co/3QWUVcl or search "One in six billion"
Ewan Pearson retweeted
📊 OUT NOW @CommsMedicine - Young et al. review the evidence on #T2D treatment effect heterogeneity with #GLP1 receptor agonists and #SGLT2 inhibitors | @DrKatieGYoung @Ademyesuf @angusgjones @john_den_ @ezpearson @ExeterMed @UoDMedicine #PMDI
nature.com/articles/s43856-0…






























